Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago – Dr Himanshu Yadav

Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago

Tagged blocks cancer case cell checkpoint colitis colorectal Cureus death Diarrhea hours ICI...15 immune inhibitor mainstay PD1 Pembrolizumab pembrolizumabinduced programmed receptor1 report sporadic Treatment

Leave a Reply